← Insider buys
APRE

Aprea Therapeutics, Inc. · Healthcare

SVP and Chief Business Officer Gregory Alan Korbel sold $134K of Aprea Therapeutics, Inc.

Sold$134,475
$4.89Price
27,500Shares
−62%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Fri, Oct 1. Filed Tue, Oct 5, 1:01 PM ET, during the session. Not investment advice.